关于核心/多) 冠型II型异构素板的合理设计
Savas Delikanli1,2, Betul Canimkurbey1,3, Pedro Ludwig Hernández-Martínez2
1Department of Electrical and Electronics Engineering, Department of Physics, UNAM - Institute of Materials Science and Nanotechnology, Bilkent University, Ankara 06800, Turkey.
Journal of the American Chemical Society
|May 9, 2023
概括
我们开发了具有II型接口的新型核心/多冠纳米板块 (NPLs),用于增强光发射. 这些异构结构实现了近单位的量子产量和更好的LED性能,为先进的光电子铺平了道路.
科学领域:
- 材料科学
- 纳米技术
- 光电子产品
背景情况:
- 解决方案处理的二维纳米板块 (NPL) 为设计异构结构提供了独特的机会.
- 在NPL上侧面的生长可以为发光和采集应用创造新的架构.
研究的目的:
- 设计和合成II型体核/多冠异质NPL.
- 研究这些新型异质NPL的光学特性和电子结构.
- 为高性能光电子设备优化异质NPL.
主要方法:
- 体II型核心/多冠异质NPL的合成.
- 光发光 (PL) 光谱分析辐射和寿命.
- 波函数计算以确认电子结构.
- 试验确定CdS,CdTe和CdSe之间的频段抵消.
主要成果:
- 在CdS/CdSeTe核心/冠状异质NPL中通过PL和计算确认了II型电子结构.
- 在CdSe/CdSeTe/CdSe/CdS核心/多冠结构中实现接近单元的PL量子产量.
- 在使用多冠异质NPL的LED中证明了卓越的性能 (36,612cd/m2,9.3%的外部量子效率).
结论:
- 开发了一种设计具有多个接口的高级II型异质NPL的途径.
- 该CdS终端层有效地抑制和抑制堆叠.
- 这些异质NPL显示出下一代LED和激光平台的巨大潜力.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
571
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
571
Structure and Function of Platelets
1.3K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.3K
Formation of the Platelet Plug
6.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K


